|The eltA elta (Catalog #MBS211617) is an Antibody produced from Mouse and is intended for research purposes only. The product is available for immediate purchase. MyBioSource\'s ESCHERICHIA COLI LABILE TOXIN A CHAIN can be used in a range of immunoassay formats including, but not limited to, ELISA (EIA), Immunofluorescence (IF), Western Blot (WB)*.
Western Blotting: Application Note: This antibody reacts with Cholera toxin A chain under reducing conditions in Western blotting. Researchers should empirically determine the suitability of the eltA elta for an application not listed in the data sheet. Researchers commonly develop new applications and it is an integral, important part of the investigative research process.
The eltA elta product has the following accession number(s) (GI #485806362) (NCBI Accession #WP_001426678.1) (Uniprot Accession #P43530). Researchers may be interested in using Bioinformatics databases such as those available at The National Center for Biotechnology Information (NCBI) website for more information about accession numbers and the proteins they represent. Even researchers unfamiliar with bioinformatics databases will find the NCBI databases to be quite user friendly and useful.
To buy or view more detailed product information and pricing, please click on the technical datasheet page below:
Mouse antiEscherichia coliLabile Toxin A Chain antibody, clone 20/480 recognizes the A chain of Escherichia coli heat-labile enterotoxin, a pathogenic peptide that activates intracellular adenyl cyclase. This antibody is reactive with isolates fixed by phenol, formalin and boiling.
Perservative Stabilisers: 0.09% Sodium Azide (NaN3)
Preparation: Purified IgG prepared by affinity chromatography on Protein G. Immunogen: Escherichia coli heat-labile enterotoxin
Buffer Solution: Phosphate buffered saline
Target Species: Bacterial. In general, we may offer more than one antibody to a given target to enable options for the researcher. Available antibodies recognizing eltA are readily searchable from our website. Different antibodies against the same target such as eltA may be optimized or tested for different applications and species. This enables researchers to select the option that may be best for their model system, to screen more than antibody to determine which one may be best for their model system, as well as to use more than one antibody to follow up on and validate their results.